BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1157 related articles for article (PubMed ID: 17182990)

  • 1. PET of brain amyloid and tau in mild cognitive impairment.
    Small GW; Kepe V; Ercoli LM; Siddarth P; Bookheimer SY; Miller KJ; Lavretsky H; Burggren AC; Cole GM; Vinters HV; Thompson PM; Huang SC; Satyamurthy N; Phelps ME; Barrio JR
    N Engl J Med; 2006 Dec; 355(25):2652-63. PubMed ID: 17182990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
    Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia.
    Small GW; Siddarth P; Burggren AC; Kepe V; Ercoli LM; Miller KJ; Lavretsky H; Thompson PM; Cole GM; Huang SC; Phelps ME; Bookheimer SY; Barrio JR
    Arch Gen Psychiatry; 2009 Jan; 66(1):81-7. PubMed ID: 19124691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid and tau imaging, neuronal losses and function in mild cognitive impairment.
    Barrio JR; Kepe V; Satyamurthy N; Huang SC; Small G
    J Nutr Health Aging; 2008 Jan; 12(1):61S-5S. PubMed ID: 18165848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults.
    Lavretsky H; Siddarth P; Kepe V; Ercoli LM; Miller KJ; Burggren AC; Bookheimer SY; Huang SC; Barrio JR; Small GW
    Am J Geriatr Psychiatry; 2009 Jun; 17(6):493-502. PubMed ID: 19472439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychological well-being and regional brain amyloid and tau in mild cognitive impairment.
    Chen ST; Siddarth P; Saito NY; Rueda F; Haight T; Ercoli LM; Miller KJ; Lavretsky H; Barrio JR; Bookheimer SY; Small GW; Merrill DA
    Am J Geriatr Psychiatry; 2014 Apr; 22(4):362-9. PubMed ID: 23567426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential FDDNP PET patterns in nondemented middle-aged and older adults.
    Ercoli LM; Siddarth P; Kepe V; Miller KJ; Huang SC; Cole GM; Lavretsky H; Bookheimer SY; Kim J; Phelps ME; Barrio JR; Small GW
    Am J Geriatr Psychiatry; 2009 May; 17(5):397-406. PubMed ID: 19390297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of dementia risk in aging adults using both FDG-PET and FDDNP-PET imaging.
    Ercoli LM; Small GW; Siddarth P; Kepe V; Huang SC; Miller KJ; Lavretsky H; Bookheimer SY; Barrio JR; Silverman DH
    Int J Geriatr Psychiatry; 2012 Oct; 27(10):1017-27. PubMed ID: 22383132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease.
    Shin J; Lee SY; Kim SH; Kim YB; Cho SJ
    Neuroimage; 2008 Nov; 43(2):236-44. PubMed ID: 18694837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-(1-{6-[(2-[fluorine-18]fluoroethyl)(methyl) amino]-2-naphthyl} ethylidene)malononitrile (FDDNP) positron emission tomography patterns in nondemented populations.
    Shin J; Lee SY
    Am J Geriatr Psychiatry; 2010 Feb; 18(2):187; author reply 188. PubMed ID: 20104075
    [No Abstract]   [Full Text] [Related]  

  • 11. Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease.
    Braskie MN; Klunder AD; Hayashi KM; Protas H; Kepe V; Miller KJ; Huang SC; Barrio JR; Ercoli LM; Siddarth P; Satyamurthy N; Liu J; Toga AW; Bookheimer SY; Small GW; Thompson PM
    Neurobiol Aging; 2010 Oct; 31(10):1669-78. PubMed ID: 19004525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease.
    Shoghi-Jadid K; Small GW; Agdeppa ED; Kepe V; Ercoli LM; Siddarth P; Read S; Satyamurthy N; Petric A; Huang SC; Barrio JR
    Am J Geriatr Psychiatry; 2002; 10(1):24-35. PubMed ID: 11790632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifiable Risk Factors and Brain Positron Emission Tomography Measures of Amyloid and Tau in Nondemented Adults with Memory Complaints.
    Merrill DA; Siddarth P; Raji CA; Emerson ND; Rueda F; Ercoli LM; Miller KJ; Lavretsky H; Harris LM; Burggren AC; Bookheimer SY; Barrio JR; Small GW
    Am J Geriatr Psychiatry; 2016 Sep; 24(9):729-37. PubMed ID: 27421618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The merits of FDDNP-PET imaging in Alzheimer's disease.
    Shin J; Kepe V; Barrio JR; Small GW
    J Alzheimers Dis; 2011; 26 Suppl 3():135-45. PubMed ID: 21971458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
    Okamura N; Furumoto S; Fodero-Tavoletti MT; Mulligan RS; Harada R; Yates P; Pejoska S; Kudo Y; Masters CL; Yanai K; Rowe CC; Villemagne VL
    Brain; 2014 Jun; 137(Pt 6):1762-71. PubMed ID: 24681664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease.
    Ikonomovic MD; Klunk WE; Abrahamson EE; Mathis CA; Price JC; Tsopelas ND; Lopresti BJ; Ziolko S; Bi W; Paljug WR; Debnath ML; Hope CE; Isanski BA; Hamilton RL; DeKosky ST
    Brain; 2008 Jun; 131(Pt 6):1630-45. PubMed ID: 18339640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seeing is believing: neuroimaging adds to our understanding of cerebral pathology.
    Small GW; Kepe V; Barrio JR
    Curr Opin Psychiatry; 2006 Nov; 19(6):564-9. PubMed ID: 17012932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid PET in mild cognitive impairment and Alzheimer's disease with BF-227: comparison to FDG-PET.
    Furukawa K; Okamura N; Tashiro M; Waragai M; Furumoto S; Iwata R; Yanai K; Kudo Y; Arai H
    J Neurol; 2010 May; 257(5):721-7. PubMed ID: 19946781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease.
    Dani M; Wood M; Mizoguchi R; Fan Z; Walker Z; Morgan R; Hinz R; Biju M; Kuruvilla T; Brooks DJ; Edison P
    Brain; 2018 Sep; 141(9):2740-2754. PubMed ID: 30052812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.